Evidence map›Paper›PMID 37125330›Full record

ArticleToxicology research2023

Integration of serum metabolomics and network pharmacology reveals the immunoenhancing mechanisms of Qishenbuqi capsules.

Ziyu Zhao, Yuhui Fan, Yutao Cui, Lan Yang, Yanfei Wu, Yuan Yuan, Ping Zhang, Ruping Zhao, Jianjun Ji, Sheng Xu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ziyu ZhaoModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.
Yuhui FanModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.
Yutao CuiModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.
Lan YangModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.
Yanfei WuThe First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Yuan YuanThe First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Ping ZhangThe Center for Disease Control and Prevention of Taiyuan, Taiyuan 030012, China.
Ruping ZhaoTaiyuan Jinyuan District Center for Disease Control and Prevention, Taiyuan 030000, China.
Jianjun JiGuangshengyuan TCM Co., Ltd, Datong 037300, China.
Sheng XuGuangshengyuan TCM Co., Ltd, Datong 037300, China.
Xuemei QinModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.ORCID https://orcid.org/0000-0002-0020-3364
Xiao-Jie LiuModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Qishenbuqi capsule (QSBQC), a listed Chinese patent prescription, comprises of 4 herbs. Clinically, it has been shown to improve immune functions. Methods: Subjects with Results: QSBQC significantly improved TCM syndrome scores and increased the number of CD8 Conclusion: Our research revealed the immunoenhancing mechanisms of QSBQC and improved the combination of TCM theory and modern western medicine theory.

Indexed as

immunitynetwork pharmacologyQishenbuqi capsulesserum metabolomics

Identifiers

PMID37125330
PMCPMC10141780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.